SS Innovations International SSII

NASDAQ SSII
$1.51 -0.10 (-6.21%)
At close: Nov 11, 2026 · 4:00 PM EST

SS Innovations International (SSII) stock price is $1.51, down 6.21% on the day, as of Nov 11, 2026. It has a market cap of $322.27Mn, and is classified in the Medical Devices industry (Healthcare sector).

Key Stats
Market Cap322.27 Mn
P/E-25.92
FCF (Yr)-22.20 Mn
ROA (Yr)-22.98
EV to EBIT-28.99
Net Income (Yr)-12.13 Mn
Enterprise Value245.88 Mn
Add ratio to table…

About

SS Innovations International, Inc. is a commercial-stage surgical robotics company that designs manufactures and markets the SSi Mantra Surgical Robotic System for use in urology general gynecology colorectal gastroenterology head and neck thoracic and cardiac surgeries. The company was founded by Dr Sudhir P Srivastava and launched commercial sales of the SSi Mantra in India in late 2022 after receiving regulatory approval from the Central Drugs Standard Control…

Read more ↓
Sector: Healthcare Sector rationale The company designs, manufactures, and markets the SSi Mantra Surgical Robotic System, which is a medical device used for various surgical procedures. Its primary customers are hospitals and healthcare facilities, and its revenue is derived from the sale of these medical systems and related surgical instruments. Industries: Medical Devices Medical Devices Primary The company designs, manufactures, and markets the SSi Mantra Surgical Robotic System, which is used for various surgical procedures including urology and cardiac surgeries. Its revenue is derived from the sale of these surgical robots and related instruments. Medical Supplies Medical Supplies Secondary The company generates recurring revenue from the sale of instruments and accessories used with its robotic systems, which are medical consumables/supplies. Classified using BQ-MICS CIK: 0001676163

Geographical Breakdown of Revenue (2025)

History
Peer percentiles

How SS Innovations International ranks

Ranked against the 250 companies in Medical Devices and Diagnostics58 metrics · as of Nov 11, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −25.9xMedian 26.3x 60th
  • P/FCFNegative free cash flow −17.7xMedian 25.8x 48th
  • P/Operating cash flowNegative operating cash flow −20.7xMedian 21.4x 47th
  • P/S 6.15xMedian 2.85x 28th
  • P/B 6.03xMedian 2.47x 23rd
  • P/Tangible book 6.03xMedian 3.15x 31st
  • EV/EBITDANegative EBITDA −43.7xMedian 18.3x 50th
  • EV/EBITNegative EBIT −37.1xMedian 28.0x 54th
  • EV/Revenue 6.01xMedian 3.08x 27th
  • EV/FCFNegative free cash flow −17.3xMedian 29.7x 41st
  • EV/Operating cash flowNegative operating cash flow −20.3xMedian 22.1x 41st
  • PEG (3Y EPS CAGR)Negative earnings 2.51Median 0.96 Not meaningful —
Peer group

Peer Comparison

Companies in the Medical Devices
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 266.22 Bn37.595.6241.37 Bn
2 ABT Abbott Laboratories 191.31 Bn40.753.9731.16 Bn
3 DHR Danaher Corp /De/ 166.16 Bn38.396.4926.48 Bn
4 ISRG Intuitive Surgical Inc 155.98 Bn53.1113.47-
5 MDT Medtronic plc 130.05 Bn14.863.5128.15 Bn
6 SYK Stryker Corp 123.40 Bn34.204.6914.93 Bn
7 BSX Boston Scientific Corp 64.81 Bn18.503.0811.95 Bn
8 SSII SS Innovations International, Inc. 0.32 Bn-25.926.150.02 Bn